Complete Characterization of the Seventeen Step Moenomycin Biosynthetic Pathway

Citations Over TimeTop 10% of 2009 papers

Abstract

The moenomycins are phosphoglycolipid antibiotics produced by Streptomyces ghanaensis and related organisms. The phosphoglycolipids are the only known active site inhibitors of the peptidoglycan glycosyltransferases, an important family of enzymes involved in the biosynthesis of the bacterial cell wall. Although these natural products have exceptionally potent antibiotic activity, pharmacokinetic limitations have precluded their clinical use. We previously identified the moenomycin biosynthetic gene cluster in order to facilitate biosynthetic approaches to new derivatives. Here, we report a comprehensive set of genetic and enzymatic experiments that establish functions for the 17 moenomycin biosynthetic genes involved in the synthesis of moenomycin and variants. These studies reveal the order of assembly of the full molecular scaffold and define a subset of seven genes involved in the synthesis of bioactive analogues. This work will enable both in vitro and fermentation-based reconstitution of phosphoglycolipid scaffolds so that chemoenzymatic approaches to novel analogues can be explored.

Related Papers

• → Lipid II: A central component in bacterial cell wall synthesis and a target for antibiotics(2008)119 cited
• → Substrate analogues to study cell-wall biosynthesis and its inhibition(2002)46 cited
• → Molecular Dynamics Studies of Lipid I and Lipid II in Various of Lipid Bilayer Environments(2015)
• → A Molecular Dynamics Simulation Study of Lipid-Linked Peptidoglycan Precursors in Lipid Bilayers(2014)
• → Choice of drugs to manage anthrax(2004)